ALEMBICLTDNSEAlembic Limited· PharmaceuticalsLowNeutral
Announced Tue, 12 Aug · 21:43 IST

Alembic Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 12, 2025

Board & Shareholder Meetings View source PDF

ALEMBICLTD · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Alembic Limited held its 118th Annual General Meeting on August 12, 2025, at 4:30 PM IST via Video Conferencing, with all directors present and 78 members in attendance. The meeting, chaired by Mr. Chirayu Amin, considered the adoption of audited standalone and consolidated financial statements for FY ended March 31, 2025, and the declaration of a dividend on equity shares for FY 2024-25. Shareholders also voted on the re-appointment of Mr. Chirayu Amin (retiring by rotation), payment of commission to Non-Executive Director Mr. Udit Amin for FY 2024-25, appointment of secretarial auditors, and ratification of cost auditors' remuneration for FY 2025-26. The meeting concluded at 4:51 PM, with e-voting results to be declared on or before August 14, 2025.

Likely market impact

This is a procedural disclosure confirming that key AGM business items, including dividend declaration and director re-appointment, have been conducted. The actual impact on shareholders will depend on the voting results (expected by August 14) and the quantum of the declared dividend, which has not been disclosed in this filing.